A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DC / Dupuytren's contracture

[Related PubMed/MEDLINE]
Total Number of Papers: 68
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DC  (>> Co-occurring Abbreviation)
Long Form:   Dupuytren's contracture
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Dupuytren's Contracture: Incidence of Injury-Induced Cases and Specific Clinical Expression. ---
2020 Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy. CCH, OT, PT
2019 Association between occupational exposure and Dupuytren's contracture using a job-exposure matrix and self-reported exposure in the CONSTANCES cohort. aOR, JEM
2019 Clostridium histolyticum as first-line treatment of Dupuytren's disease. MCP, PIP
2019 Dupuytren contracture as a sign of systemic disease. ---
2019 Dupuytren's disease: limited fasciectomy, night splinting, and hand exercises-long-term results. ---
2019 Efficacy of collagenase Clostridium histolyticum injection for Dupuytren's contracture in East-Asian population. CCH, MCP, PIP
2019 Going beyond Activity and Participation: Development of the DIF-CHUM-A patient-reported outcome measure for individuals with Dupuytren's contracture. DIF-CHUM, PROs
2019 Hand therapy or not following collagenase treatment for Dupuytren's contracture? Protocol for a randomised controlled trial. MCPJ, PIPJ
10  2019 Percutaneous needle aponeurotomy for the treatment of Dupuytren's contracture. ---
11  2019 The Effect of Chitosan Derivatives on the Compaction and Tension Generation of the Fibroblast-populated Collagen Matrix. aFPCM, OCT, TGF-beta1
12  2019 [Therapy of Dupuytren's contracture with collagenase - Evidence-based Consensus Statement of Austrian Surgical Societies]. CCH, DD
13  2018 DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture. DETECT, PASS
14  2018 The Incidence of Complex Regional Pain Syndrome in Simultaneous Surgical Treatment of Carpal Tunnel Syndrome and Dupuytren Contracture. CRPS, CTS
15  2017 Dupuytren's contracture and handwork: A case-control study. HHW, RHW
16  2017 Prevalence of Peyronie's Disease-Like Symptoms in Men Presenting With Dupuytren Contractures. PD, PDLS
17  2017 The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting. CCH, MCP, PIP
18  2016 Musculoskeletal disorders of the hand in type 2 diabetes mellitus: prevalence and its associated factors. CTS, LJM, T2DM
19  2016 The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States. CCH, NA
20  2015 Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome. CCH, MCP, PIP
21  2015 Identification and function analysis of contrary genes in Dupuytren's contracture. GO, NF-kappaB
22  2015 Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy? CTS, DD, IL, RT, TGF, VEGF
23  2015 Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren's contracture. Akt, bFGF, CTGF, IGF2, qPCR
24  2015 Screening of candidate genes in fibroblasts derived from patients with Dupuytren's contracture using bioinformatics analysis. C10orf10, DEGs, FBN2, FGF22, KLHDC7A, NR4A1, PRKCE, SLCO2A1, ZNF516
25  2014 Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study. MCP, PIP
26  2014 Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000days. CCH, MP, PIP, REMS
27  2014 Prevalence and risk factors of five most common upper extremity disorders in diabetics. CTS, LJM, SC, TF
28  2014 The contribution of HLA molecules to Dupuytren's contracture in a Southeast Brazilian population. ---
29  2014 The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture. CCH
30  2014 The prevalence of Dupuytren contractures in patients with psoriasis. ---
31  2014 [Metabolism of collagen in patients with Dupuitren's contracture]. ---
32  2013 Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment. DCE
33  2013 Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture. CCH, DASH
34  2013 Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture. alpha-SMA, CCT-eta, CT, FPCLs, PF
35  2013 Surgical management of Dupuytren's contracture in Europe: regional analysis of a surgeon survey and patient chart review. ---
36  2012 Direct and indirect costs associated with Dupuytren's contracture. ---
37  2012 Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands. ---
38  2012 Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. AEs, CCH, FFC, ROM
39  2012 Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture. ---
40  2012 Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study. AEs, CCH, MP, PIP
41  2011 Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England. ---
42  2011 Prevalence and pattern of hand soft-tissue changes in type 2 diabetes mellitus. CTS, LJM
43  2011 Reversal of TGF-beta1 stimulation of alpha-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts. alpha-SMA, cAMP, CTGF, CTR, ECM, PF, TGF-beta1
44  2011 [Morphological criteria of the operative tactics substantiation in Dupuytren's contracture in patients with chronic hepatitis]. ---
45  2008 Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture. Fbln1, PRG4, SAM
46  2008 No gene copy number changes in Dupuytren's contracture by array comparative genomic hybridization. ---
47  2007 Beta-catenin signaling in fibroproliferative disease. ---
48  2007 Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. AEs, MCP, PIP
49  2007 Immunohistochemical evidence of nerve growth factor in Dupuytren's diseased palmar fascia. NGF, TGF
50  2006 Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS). PBM, PBSII, SAM, SELDI-TOF-MS
51  2005 A cohort study linked increased mortality in patients treated surgically for Dupuytren's contracture. SMR
52  2004 Abductor digiti minimi involvement in Dupuytren's contracture of the small finger. ADM, PIPJ
53  2003 Activation markers of connective tissue in Dupuytren's contracture: relation to postoperative outcome. ---
54  2001 Acute postoperative swelling after hand surgery: an exploratory, double-blind, randomised study with paracetamol, naproxen, and placebo. CTS
55  2001 Radiotherapy optimization in early-stage Dupuytren's contracture: first results of a randomized clinical study. FU, RT
56  2000 Cancer incidence in patients treated surgically for Dupuytren's contracture. SIRs
57  1996 Can Dupuytren's contracture be work-related?: review of the evidence. CIs, ORs
58  1994 Prevalence of HLA-DR3 and autoantibodies to connective tissue components in Dupuytren's contracture. ---
59  1993 Hand abnormalities are strongly associated with the duration of diabetes mellitus. CTS, FTS, LJM
60  1992 Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease. FGF
61  1992 Basic fibroblast growth factor in Dupuytren's contracture. ---
62  1991 Association between connective tissue changes and smoking habit in type 2 diabetes and in non-diabetic humans. LJM, LJM
63  1991 [Association of cheiroarthropathy and Dupuytren's disease in diabetes mellitus]. LJM
64  1989 Dupuytren's contracture. Fine structure in relation to aetiology. CTS
65  1987 Dupuytren's contracture, alcohol consumption, and chronic liver disease. ---
66  1986 Dupuytren's contracture and alcohol. GGT, MCV, sUA
67  1983 The relationship of hand abnormalities to diabetes and diabetic retinopathy. LJM
68  1975 Significance of histopathological findings in Dupuytren's contracture. HID-AB